elearning

Register for free and gain unlimited access to our extensive elearning library
Earn CME points and track your learning activity with hundreds of hours of continuing medical education.
Bookmark and Share

Pharmacological Treatment for Tobacco Dependence

This module focuses on the pharmacological treatments available to smokers during a quit attempt, including; nicotine replacement therapy (NRT), varenicline, bupropion and cytisine and their effectiveness in promoting a successful quit attempt. 

This e-learning course is comprised of 8 modules exploring how to deliver an effective cessation programme to your patients. The content was developed alongside experts in Tobacco Cessation from King's College London.

Published November 2017.

Pharmacological Treatment for Tobacco Dependence
Module
English
0 CME Points

Target audience

This module is for health professionals/students looking to expand their knowledge in the field of tobacco addiction with a focus on tobacco dependence treatment.

Learning objectives

Participants will gain knowledge and understanding of:

  • Evidence based medicines to help smokers quit, including nicotine replacement therapy, varenicline bupropion and cytisine.

IT Requirements

This module requires the learner to have a good, stable internet connection and can run on Internet Explorer 7 and above, Mozilla Firefox, Google Chrome and Opera on either Windows or MacOS. Flash Add-on is also required to run this module.

If you are viewing this module on an iPad (through a browser), please download the free Articulate Mobile Player beforehand. Other tablet devices may not be compatible - please check for Flash compatibility.

If you are experiencing technical difficulties, please contact education@ecancer.org and we will get back to you as soon as possible.

Disclosure policy

ecancer and everyone involved in the development of this module has no actual or potential conflict of interest whatsoever which impinges on the making, peer reviewing and dissemination of this e-learning module which was made possible through an unrestricted educational grant from Pfizer.

Support

Production of this module was funded by an unrestricted grant from Pfizer.